栀子苷调控 AMPK/ mTOR/ ULK1 通路对肺癌细胞增殖、凋亡和自噬的影响
作者:
作者单位:

1.胜利油田中心医院胸外科,山东 东营 257000;2.胜利油田中心医院肿瘤科,山东 东营 257000;3.胜利油田中心医院外科,山东 东营 257000

作者简介:

通讯作者:

中图分类号:

R-33

基金项目:


Impacts of geniposide on proliferation, apoptosis, and autophagy in lung cancer cells via the AMPK / mTOR / ULK1 pathway
Author:
Affiliation:

1. Thoracic Surgery Department, Shengli Oilfield Central Hospital, Dongying 257000, China. 2. Oncology Department,Shengli Oilfield Central Hospital, Dongying 257000. 3. Surgery Department, Shengli Oilfield Central Hospital,Dongying 257000

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨栀子苷调控单磷酸腺苷活化蛋白激酶( AMPK) / 哺乳动物雷帕霉素靶蛋白(mTOR) / Unc-51 样激酶 1(ULK1)通路对肺癌细胞增殖、凋亡和自噬的影响。 方法 A549 细胞分为肺癌组、栀子苷低剂量组、栀子苷中剂量组、栀子苷高剂量组、AMPK 激活剂(MK8722)组、栀子苷高剂量+AMPK 抑制剂(Compound C)组,5-乙炔基-2’脱氧尿嘧啶核苷(EdU)染色、CCK-8 法检测细胞增殖;流式细胞术检测细胞凋亡;透射电镜观察 A549 细胞中自噬小体数;RT-qPCR 检测 A549 细胞中增殖细胞核抗原(PCNA)、p53、p62、Bcl-2 同源结构域蛋白(Beclin1) mRNA 表达;Western blot 检测 A549 细胞微管相关蛋白 1 轻链 3( LC3)、pAMPK、p-mTOR、p-ULK1 蛋白。 结果 与肺癌组比较,栀子苷低、中、高剂量组 A549 细胞 EdU 阳性率、OD450值、PCNA、p62 mRNA 及 p-mTOR 蛋白降低,细胞凋亡率、自噬小体数、p53、Beclin1 mRNA 及 LC3-II/ LC3-I、pAMPK、p-ULK1 蛋白升高,且栀子苷高剂量组趋势最明显(P<0. 05);与肺癌组比较,MK8722 组 A549 细胞EdU 阳性率、OD450 值、PCNA、p62 mRNA 及 p-mTOR 蛋白降低,细胞凋亡率、自噬小体数、p53、Beclin1 mRNA及 LC3-II/ LC3-I、p-AMPK、p-ULK1 蛋白升高(P<0. 05);与栀子苷高剂量组比较,栀子苷高剂量+Compound C组 A549 细胞 EdU 阳性率、OD450 值、PCNA、p62 mRNA 及 p-mTOR 蛋白升高(P<0. 05),细胞凋亡率、自噬小体数、p53、Beclin1 mRNA 及 LC3-II/ LC3-I、p-AMPK、p-ULK1 蛋白降低(P<0. 05)。 结论 栀子苷可能通过激活AMPK/ mTOR/ ULK1 通路抑制 A549 细胞增殖,促进细胞自噬和凋亡。

    Abstract:

    Objective To discuss the effects of geniposide on proliferation, apoptosis, and autophagy in lung cancer cells by regulating the adenosine monophosphate-activated protein kinase (AMPK) / mammalian target of rapamycin (mTOR) / unc-51 like kinase 1 (ULK1) pathway. Methods A549 cells were divided into lung cancer,low-dose geniposide, medium-dose geniposide, high-dose geniposide, AMPK activator (MK8722), and high-dose geniposide+AMPK inhibitor (Compound C) groups. 5-Ethynyl-2’ deoxyuridine (EdU) staining and CCK-8 assays were used to detect cell proliferation. Flow cytometry was used to detect cell apoptosis. Transmission electron microscopy was used to count autophagosomes in A549 cells. RT-qPCR was used to detect the mRNA expression of proliferating cell nuclear antigen ( PCNA), p53, p62, and Bcl-2 homologous domain protein ( Beclin1) in A549 cells. Western blot was used to detect microtubule associated protein 1 light chain 3 (LC3), p-AMPK, p-mTOR, and p-ULK1 in A549 cells. Results Compared with levels in the lung cancer group, the low-, medium-, and high-dose geniposide groups showed decreases in the EdU-positive rate, OD450 value, PCNA and p62 mRNA levels, and pmTOR protein expression in A549 cells and increases in the apoptosis rate, autophagosome number, p53 and Beclin1 mRNA levels, and LC3-II/ LC3-I, p-AMPK, and p-ULK1 protein levels; the high-dose geniposide group showed the most prominent differences (P<0. 05). Compared with levels in the lung cancer group, the MK8722 group showed decreases in the EdU-positive rate, OD450 value, PCNA and p62 mRNA levels, and p-mTOR protein expression in A549 cells and increases in the apoptosis rate, autophagosome number, p53 and Beclin1 mRNA levels(P<0. 05), and LC3-II/ LC3-I, p-AMPK, and p-ULK1 protein levels ( P< 0. 05). Compared with levels in the high-dose geniposide group, the high-dose geniposide+Compound C group showed increases in the EdU-positive rate, OD450 value, PCNA and p62 mRNA levels, and p-mTOR protein levels in A549 cells and decreases in the apoptosis rate,autophagosome number, p53 and Beclin1 mRNA levels ( P< 0. 05), and LC3-II/ LC3-I, p-AMPK, and p-ULK1 protein levels (P<0. 05). Conclusions Geniposide may inhibit A549 cell proliferation and promote autophagy and apoptosis through activating the AMPK/ mTOR/ ULK1 pathway.

    参考文献
    相似文献
    引证文献
引用本文

陈 丹,单连良,张婷婷,孙 平.栀子苷调控 AMPK/ mTOR/ ULK1 通路对肺癌细胞增殖、凋亡和自噬的影响[J].中国比较医学杂志,2025,35(11):30~38.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-05-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-12
  • 出版日期: